Clinical Trial Update: A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer

View source ↗

Summary

This document reports on a clinical trial evaluating a novel multiplex ELISA assay to evaluate patients with gross hematuria for bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Bladder Cancer | Status: ACTIVE_NOT_RECRUITING